vs
PPL Corporation（PPL）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
PPL Corporation的季度营收约是Steris的1.6倍（$2.3B vs $1.5B），Steris净利率更高（12.9% vs 11.3%，领先1.6%），Steris同比增速更快（9.2% vs 7.2%），Steris自由现金流更多（$199.5M vs $-614.0M），过去两年Steris的营收复合增速更高（15.8% vs 1.0%）
PPL公司是总部位于美国宾夕法尼亚州的能源公用事业控股企业，为宾州、肯塔基州、罗德岛州约350万居民及工商业用户提供电力与天然气供应服务，核心业务方向包括电网现代化升级、清洁能源转型、高可靠性可持续能源服务供给。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
PPL vs STE — 直观对比
营收规模更大
PPL
是对方的1.6倍
$1.5B
营收增速更快
STE
高出2.0%
7.2%
净利率更高
STE
高出1.6%
11.3%
自由现金流更多
STE
多$813.5M
$-614.0M
两年增速更快
STE
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.3B | $1.5B |
| 净利润 | $266.0M | $192.9M |
| 毛利率 | — | 43.8% |
| 营业利润率 | 20.3% | 18.3% |
| 净利率 | 11.3% | 12.9% |
| 营收同比 | 7.2% | 9.2% |
| 净利润同比 | 50.3% | 11.2% |
| 每股收益（稀释后） | $0.35 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PPLSTE
| Q4 25 | $2.3B | $1.5B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $2.0B | $1.4B | ||
| Q1 25 | $2.5B | $1.5B | ||
| Q4 24 | $2.2B | $1.4B | ||
| Q3 24 | $2.1B | $1.3B | ||
| Q2 24 | $1.9B | $1.3B | ||
| Q1 24 | $2.3B | $1.1B |
净利润PPLSTE
| Q4 25 | $266.0M | $192.9M | ||
| Q3 25 | $318.0M | $191.9M | ||
| Q2 25 | $183.0M | $177.4M | ||
| Q1 25 | $414.0M | $145.7M | ||
| Q4 24 | $177.0M | $173.5M | ||
| Q3 24 | $214.0M | $150.0M | ||
| Q2 24 | $190.0M | $145.4M | ||
| Q1 24 | $307.0M | $-1.4M |
毛利率PPLSTE
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 44.2% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 43.6% | ||
| Q2 24 | — | 44.7% | ||
| Q1 24 | — | 40.2% |
营业利润率PPLSTE
| Q4 25 | 20.3% | 18.3% | ||
| Q3 25 | 25.4% | 18.2% | ||
| Q2 25 | 19.9% | 17.7% | ||
| Q1 25 | 26.6% | 14.6% | ||
| Q4 24 | 17.2% | 17.9% | ||
| Q3 24 | 20.6% | 16.5% | ||
| Q2 24 | 20.8% | 14.5% | ||
| Q1 24 | 23.7% | 22.0% |
净利率PPLSTE
| Q4 25 | 11.3% | 12.9% | ||
| Q3 25 | 14.2% | 13.1% | ||
| Q2 25 | 9.0% | 12.8% | ||
| Q1 25 | 16.3% | 9.8% | ||
| Q4 24 | 8.1% | 12.7% | ||
| Q3 24 | 10.3% | 11.3% | ||
| Q2 24 | 10.1% | 11.4% | ||
| Q1 24 | 13.3% | -0.1% |
每股收益（稀释后）PPLSTE
| Q4 25 | $0.35 | $1.96 | ||
| Q3 25 | $0.43 | $1.94 | ||
| Q2 25 | $0.25 | $1.79 | ||
| Q1 25 | $0.56 | $1.48 | ||
| Q4 24 | $0.23 | $1.75 | ||
| Q3 24 | $0.29 | $1.51 | ||
| Q2 24 | $0.26 | $1.46 | ||
| Q1 24 | $0.42 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $423.7M |
| 总债务越低越好 | $18.9B | $1.9B |
| 股东权益账面价值 | $14.9B | $7.2B |
| 总资产 | $45.2B | $10.6B |
| 负债/权益比越低杠杆越低 | 1.27× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资PPLSTE
| Q4 25 | $1.1B | $423.7M | ||
| Q3 25 | $1.1B | $319.2M | ||
| Q2 25 | $294.0M | $279.7M | ||
| Q1 25 | $312.0M | $171.7M | ||
| Q4 24 | $306.0M | $155.2M | ||
| Q3 24 | $542.0M | $172.2M | ||
| Q2 24 | $282.0M | $198.3M | ||
| Q1 24 | $276.0M | $207.0M |
总债务PPLSTE
| Q4 25 | $18.9B | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | $16.5B | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $3.1B |
股东权益PPLSTE
| Q4 25 | $14.9B | $7.2B | ||
| Q3 25 | $14.4B | $7.0B | ||
| Q2 25 | $14.3B | $7.0B | ||
| Q1 25 | $14.3B | $6.6B | ||
| Q4 24 | $14.1B | $6.4B | ||
| Q3 24 | $14.1B | $6.6B | ||
| Q2 24 | $14.1B | $6.4B | ||
| Q1 24 | $14.1B | $6.3B |
总资产PPLSTE
| Q4 25 | $45.2B | $10.6B | ||
| Q3 25 | $43.9B | $10.4B | ||
| Q2 25 | $42.4B | $10.4B | ||
| Q1 25 | $41.8B | $10.1B | ||
| Q4 24 | $41.1B | $10.0B | ||
| Q3 24 | $40.5B | $10.2B | ||
| Q2 24 | $39.8B | $10.1B | ||
| Q1 24 | $39.6B | $11.1B |
负债/权益比PPLSTE
| Q4 25 | 1.27× | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | 1.17× | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $548.0M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $-614.0M | $199.5M |
| 自由现金流率自由现金流/营收 | -26.1% | 13.3% |
| 资本支出强度资本支出/营收 | 49.5% | 6.6% |
| 现金转化率经营现金流/净利润 | 2.06× | 1.55× |
| 过去12个月自由现金流最近4个季度 | $-1.4B | $917.1M |
8季度趋势，按日历期对齐
经营现金流PPLSTE
| Q4 25 | $548.0M | $298.2M | ||
| Q3 25 | $966.0M | $287.8M | ||
| Q2 25 | $602.0M | $420.0M | ||
| Q1 25 | $513.0M | $260.8M | ||
| Q4 24 | $511.0M | $332.8M | ||
| Q3 24 | $781.0M | $250.7M | ||
| Q2 24 | $766.0M | $303.7M | ||
| Q1 24 | $282.0M | $254.8M |
自由现金流PPLSTE
| Q4 25 | $-614.0M | $199.5M | ||
| Q3 25 | $-179.0M | $201.3M | ||
| Q2 25 | $-328.0M | $326.4M | ||
| Q1 25 | $-280.0M | $189.9M | ||
| Q4 24 | $-349.0M | $243.6M | ||
| Q3 24 | $102.0M | $148.8M | ||
| Q2 24 | $96.0M | $195.7M | ||
| Q1 24 | $-314.0M | $163.3M |
自由现金流率PPLSTE
| Q4 25 | -26.1% | 13.3% | ||
| Q3 25 | -8.0% | 13.8% | ||
| Q2 25 | -16.1% | 23.5% | ||
| Q1 25 | -11.0% | 12.8% | ||
| Q4 24 | -15.9% | 17.8% | ||
| Q3 24 | 4.9% | 11.2% | ||
| Q2 24 | 5.1% | 15.3% | ||
| Q1 24 | -13.6% | 14.6% |
资本支出强度PPLSTE
| Q4 25 | 49.5% | 6.6% | ||
| Q3 25 | 51.2% | 5.9% | ||
| Q2 25 | 45.6% | 6.7% | ||
| Q1 25 | 31.2% | 4.8% | ||
| Q4 24 | 39.3% | 6.5% | ||
| Q3 24 | 32.7% | 7.7% | ||
| Q2 24 | 35.8% | 8.4% | ||
| Q1 24 | 25.9% | 8.2% |
现金转化率PPLSTE
| Q4 25 | 2.06× | 1.55× | ||
| Q3 25 | 3.04× | 1.50× | ||
| Q2 25 | 3.29× | 2.37× | ||
| Q1 25 | 1.24× | 1.79× | ||
| Q4 24 | 2.89× | 1.92× | ||
| Q3 24 | 3.65× | 1.67× | ||
| Q2 24 | 4.03× | 2.09× | ||
| Q1 24 | 0.92× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PPL
| Rhode Island Regulated | $539.0M | 23% |
| Other | $532.0M | 23% |
| Residential | $451.0M | 19% |
| Nonrelated Party | $425.0M | 18% |
| Transmission | $228.0M | 10% |
| Commercial | $117.0M | 5% |
| Wholesale Other | $23.0M | 1% |
| Industrial | $14.0M | 1% |
| Related Party | $13.0M | 1% |
| Wholesale Municipal | $6.0M | 0% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
